Inna Y Gong

8PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 15, 2026
Association of comorbidity burden with cause-specific survival after CAR T therapy for large B-cell lymphoma.

|Mar 03, 2026
Outcomes of Bridging Therapy in Patients With Relapsed/Refractory Large B Cell Lymphoma Receiving Third-Line CAR T.

Inna Y Gong, Meenakshi Jeeva, Katrina Hueniken

|Jan 05, 2026
Management of relapsed/refractory DLBCL in the era of novel agents and new approaches.

Inna Y Gong, John Kuruvilla

|Aug 23, 2024
Biomarkers of outcome in patients undergoing CD19 CAR-T therapy for large B cell lymphoma.

Inna Y Gong, Daisy Tran, Samuel Saibil

|Oct 27, 2023
Indolent lymphoma care delivery and outcomes during the COVID-19 pandemic in Ontario, Canada.

Inna Y Gong, Anca Prica, Zharmaine Ante

|Aug 02, 2023
Mortality among patients with diffuse large B-cell lymphoma and mental disorders: a population-based study.

Inna Y Gong, Matthew C Cheung, Kelvin K W Chan

Pageof 2

Frequent Collaborators

2 joint publications

Abi Vijenthira

2 joint publications

Matthew C Cheung

2 joint publications

John Kuruvilla

1 joint publications

Paul Kurdyak